Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

United Therapeutics (UTHR) Goodwill (2016 - 2024)

Historic Goodwill for United Therapeutics (UTHR) over the last 15 years, with Q4 2024 value amounting to $32.3 million.

  • United Therapeutics' Goodwill fell 415.43% to $32.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $32.3 million, marking a year-over-year decrease of 415.43%. This contributed to the annual value of $32.3 million for FY2024, which is 415.43% down from last year.
  • According to the latest figures from Q4 2024, United Therapeutics' Goodwill is $32.3 million, which was down 415.43% from $33.7 million recorded in Q4 2023.
  • United Therapeutics' 5-year Goodwill high stood at $33.7 million for Q4 2023, and its period low was $28.0 million during Q1 2020.
  • Moreover, its 5-year median value for Goodwill was $28.0 million (2020), whereas its average is $28.7 million.
  • Its Goodwill has fluctuated over the past 5 years, first tumbled by 1111.11% in 2020, then surged by 2035.71% in 2023.
  • United Therapeutics' Goodwill (Quarter) stood at $28.0 million in 2020, then changed by 0.0% to $28.0 million in 2021, then changed by 0.0% to $28.0 million in 2022, then grew by 20.36% to $33.7 million in 2023, then fell by 4.15% to $32.3 million in 2024.
  • Its Goodwill stands at $32.3 million for Q4 2024, versus $33.7 million for Q4 2023 and $28.0 million for Q4 2022.